title: Effects of inflammatory mediators on the responsiveness of isolated human airways to methacholine.
abstract: Several studies have suggested that in asthmatics the quantities of inflammatory mediators such as histamine, thromboxane A2 (TxA2), prostaglandin D2 (PGD2), prostaglandin F2 alpha (PGF2 alpha), and leukotriene C4 (LTC4) that are present in the airway lumen are related to the degree of bronchial responsiveness to inhaled methacholine (MCh). Therefore, we studied the effect of these mediators on the cholinergic responsiveness of isolated human airway segments. Lung tissue collected at thoracotomy from 30 patients was studied. Dose-response curves to MCh were obtained from bronchial segments before, during, and after incubation with either a subthreshold or a threshold concentration of histamine (10(-10) or 10(-8) M), the stable TxA2 analogue U46619 (10(-11) or 10(-9) M), PGD2 (5 x 10(-9) or 5 x 10(-7) M), PGF2 alpha (10(-9) or 10(-7) M), or LTC4 (10(-11) or 10(-9) M). With the exception of LTC4, the presence of any of these mediators at either concentration increased the sensitivity to MCh by a factor of 1.1 to 2 (p less than 0.05, ANOVA). This increase did not depend on the dose of the mediator (p greater than 0.05, ANOVA). These data indicate that mediator-induced muscle hypersensitivity can explain a small part of the leftward shift of the dose-response curve to inhaled MCh as observed in asthma.
authors.affiliation: Division of Pediatric Respiratory Medicine, Erasmus University, Rotterdam, The Netherlands.
authors.forename: R C
authors.initials: RC
authors.lastname: Jongejan
authors.forename: J C
authors.initials: JC
authors.lastname: de Jongste
authors.forename: R C
authors.initials: RC
authors.lastname: Raatgeep
authors.forename: T
authors.initials: T
authors.lastname: Stijnen
authors.forename: I L
authors.initials: IL
authors.lastname: Bonta
authors.forename: K F
authors.initials: KF
authors.lastname: Kerrebijn
mesh_terms: D000368:Aged; D001980:Bronchi / Q000187:drug effects* / Q000502:physiology; D015237:Dinoprost / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007249:Inflammation / Q000503:physiopathology; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology*; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects*; D015230:Prostaglandin D2 / Q000494:pharmacology; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D013189:SRS-A / Q000494:pharmacology
chemical_list: D011450:Prostaglandin Endoperoxides, Synthetic; D013189:SRS-A; D016210:Methacholine Chloride; D006632:Histamine; D015237:Dinoprost; D015230:Prostaglandin D2